Chronic Therapy With Elamipretide (MTP-131), a Novel Mitochondria-Targeting Peptide, Improves Left Ventricular and Mitochondrial Function in Dogs With Advanced Heart Failure

Circulation. Heart Failure
Hani N SabbahKefei Zhang

Abstract

Elamipretide (MTP-131), a novel mitochondria-targeting peptide, was shown to reduce infarct size in animals with myocardial infarction and improve renal function in pigs with acute and chronic kidney injury. This study examined the effects of chronic therapy with elamipretide on left ventricular (LV) and mitochondrial function in dogs with heart failure (HF). Fourteen dogs with microembolization-induced HF were randomized to 3 months monotherapy with subcutaneous injections of elamipretide (0.5 mg/kg once daily, HF+ELA, n=7) or saline (control, HF-CON, n=7). LV ejection fraction, plasma n-terminal pro-brain natriuretic peptide, tumor necrosis factor-α, and C-reactive protein were measured before (pretreatment) and 3 months after initiating therapy (post-treatment). Mitochondrial respiration, membrane potential (Δψm), maximum rate of ATP synthesis, and ATP/ADP ratio were measured in isolated LV cardiomyocytes obtained at post-treatment. In HF-CON dogs, ejection fraction decreased at post-treatment compared with pretreatment (29 ± 1% versus 31 ± 2%), whereas in HF+ELA dogs, ejection fraction significantly increased at post-treatment compared with pretreatment (36 ± 2% versus 30 ± 2%; P<0.05). In HF-CON, n-terminal pro-brain natri...Continue Reading

References

Nov 1, 1992·Journal of Molecular and Cellular Cardiology·H N SabbahS Goldstein
Jun 7, 1995·Molecular and Cellular Biochemistry·H N SabbahS Goldstein
Oct 14, 1998·Journal of Molecular and Cellular Cardiology·V G SharovH N Sabbah
Dec 13, 2000·Journal of Molecular and Cellular Cardiology·V G SharovH N Sabbah
Dec 20, 2002·The Journal of Pharmacology and Experimental Therapeutics·Kesheng ZhaoHazel H Szeto
Oct 29, 2005·The Journal of Physiology·David J MarcinekKevin E Conley
Aug 20, 2008·Cardiovascular Research·Mariana G RoscaCharles L Hoppel
Jan 27, 2009·Biochimica Et Biophysica Acta·Andrew P Halestrap, Philippe Pasdois
Sep 16, 2009·The Journal of Cell Biology·Rachel M DeVayJodi Nunnari
May 7, 2011·Journal of the American Society of Nephrology : JASN·Hazel H SzetoSurya V Seshan
Apr 14, 2012·Circulation Research·Dao-Fu DaiZoltan Ungvari
Oct 2, 2012·Circulation Research·Joseph R BurgoyneAjay M Shah
Nov 7, 2012·Journal of the American Heart Association·Robert A KlonerDavid A Brown
Jul 3, 2013·Journal of the American Society of Nephrology : JASN·Alexander V BirkHazel H Szeto
Nov 6, 2013·Chemistry and Physics of Lipids·Quan He, Xianlin Han
Nov 30, 2013·Journal of Cardiovascular Pharmacology and Therapeutics·David A BrownRobert A Kloner
Apr 7, 2015·Biochimica Et Biophysica Acta·Luis Alberto Luévano-MartínezAlicia J Kowaltowski

❮ Previous
Next ❯

Citations

Jan 21, 2017·The Journal of Physiology·Michael KohlhaasChristoph Maack
Sep 17, 2017·Circulation. Cardiovascular Interventions·Robert A Kloner
Dec 9, 2017·Circulation. Heart Failure·Douglas L Mann
Oct 9, 2018·European Heart Journal·Christoph MaackAlexandre Mebazaa
Nov 6, 2018·Nature Reviews. Drug Discovery·Michael P Murphy, Richard C Hartley
Oct 10, 2018·Annual Review of Pharmacology and Toxicology·Ravi B Patel, Sanjiv J Shah
Mar 12, 2019·Circulation·Anupam A KumarJulio A Chirinos
Dec 23, 2016·Nature Reviews. Cardiology·David A BrownMihai Gheorghiade
May 28, 2019·Cell and Tissue Research·Lucia-Doina Popov
Jul 13, 2019·Cardiovascular Research·Kristen J BubbGemma A Figtree
Aug 16, 2019·European Journal of Preventive Cardiology·Alberto AimoAlberto Giannoni
Sep 6, 2017·European Journal of Heart Failure·Andrew J Stewart Coats
Sep 1, 2019·Current Pharmaceutical Design·Caroline D VelosoPaulo J Oliveira
Feb 10, 2017·Future Cardiology·Joseph J CuthbertAndrew L Clark
Feb 11, 2020·Journal of Cellular and Molecular Medicine·Marten SziborHoward T Jacobs
Mar 9, 2020·Cardiovascular Drugs and Therapy·Hani N SabbahMartin Emanuele
Mar 21, 2017·American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions·Bharathi Upadhya, Dalane W Kitzman
Feb 6, 2017·Cardiovascular Research·Jan Dudek, Christoph Maack
Dec 16, 2016·European Journal of Heart Failure·Hani N Sabbah
Nov 25, 2016·Journal of the American Society of Nephrology : JASN·Hazel H SzetoTorgny Gustafsson
Apr 1, 2020·Frontiers in Cardiovascular Medicine·Alessandra MurabitoAlessandra Ghigo
Oct 24, 2017·Scientific Reports·Maria Lucia Dell'AnnaMauro Picardo
Dec 21, 2019·Experimental & Molecular Medicine·Jessica N PeoplesJennifer Q Kwong
Apr 3, 2020·Clinical Research in Cardiology : Official Journal of the German Cardiac Society·Jan WintrichMichael Böhm
Nov 1, 2016·Expert Review of Cardiovascular Therapy·Hani N Sabbah
Jun 22, 2018·Frontiers in Cardiovascular Medicine·Qutuba G KarwiGary D Lopaschuk
Apr 25, 2019·Pflügers Archiv : European journal of physiology·Dae Yun SeoJin Han
Jun 1, 2018·Annals of Geriatric Medicine and Research·Hyoung Moo Park
May 12, 2018·Circulation Research·Edoardo Bertero, Christoph Maack
Mar 14, 2019·Journal of Molecular Medicine : Official Organ of the Gesellschaft Deutscher Naturforscher Und Ärzte·Maurizio ForteSperanza Rubattu
May 8, 2019·JACC. Basic to Translational Science·Muhammad Shahzeb Khan, Javed Butler
May 8, 2019·JACC. Basic to Translational Science·Kathryn C ChatfieldBrian L Stauffer

❮ Previous
Next ❯

Related Concepts

Related Feeds

ATP Synthases

ATP synthases are enzymes located in the inner mitochondrial membrane that catalyze the synthesis of ATP during cellular respiration. Discover the latest research on ATP synthases here.